# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: SST-SKIN: Skin infection

Extent: E+W+S+N.I.

Skin infections must meet at least one of the following criteria:
Patient has purulent drainage, pustules, vesicles, or boils
Patient has at least two of the following signs or symptoms with no other recognized cause: pain or tenderness, localized swelling, redness, or heat
AND at least one of the following:
organisms cultured from aspirate or drainage from affected site; if organisms are normal skin flora (for example, diphtheroids (Corynebacterium spp.), Bacillus (not B. anthracis) spp., Propionibacterium spp., coagulase-negative staphylococci (including Staphylococcus epidermidis), viridans group streptococci, Aerococcus spp., Micrococcus spp.), they must be a pure culture
organisms cultured from blood
positive antigen test performed on infected tissue or blood
multinucleated giant cells seen on microscopic examination of affected tissue
diagnostic single antibody titre (IgM) or 4-fold increase in paired sera (IgG) for pathogen

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/4/division/4.1/division/4.1.13/division/1 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-4/division-4.1/division-4.1.13/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.